Skip to main content
. 2015 Jan 6;43(2):1069–1080. doi: 10.1093/nar/gku1328

Figure 5.

Figure 5.

YK-4-279 negates the inhibitory effect of EWS-FLI1 on RHA in an enantiomer-specific manner and alters the profile of bound RNA. (A) Recombinant RHA (1 nM) in the presence of recombinant EWS-FLI1 (1 nM) or small molecules (30 μM). Helicase reactions carried out as shown above in Figure 1. (B) Triplicate results of helicase reactions were plotted over time. The x-axis is time in seconds and the y-axis is percent product formation in the helicase assay. (C) Scheme used for RNA immunoprecipitation (RIP) of RHA or EWS-FLI1 protein complexes. TC32 ES cells either treated with DMSO or 3-μM YK-4-279 for 8 h. Extraction of RNA associated with RHA or EWS-FLI1 complexes was followed by Illumina sequencing. (D) 1345 transcripts were found common in RHA or EWS-FLI1 RIP. YK-4-279 changes the profile of 1345 RNA bound to the proteins. i: after YK-4-279 treatment, 615 of 1345 RNAs were immunoprecipitated separately by either RHA or EWS-FLI1 antibodies. ii: 306 transcripts were immunoprecipitated by EWS-FLI1. iii: RHA RIP yielded 243 transcripts. iv: 181 transcripts were not found in sequencing from either IP reaction.